March 2, 2020 / 1:51 PM / a month ago

BRIEF-Mallinckrodt Initiates Rolling Submission Of NDA To The U.S. FDA For Terlipressin

March 2 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT INITIATES ROLLING SUBMISSION OF NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR TERLIPRESSIN FOR THE TREATMENT OF PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 (HRS-1)

* MALLINCKRODT - EXPECTS TO COMPLETE SUBMISSION OF NDA IN COMING MONTHS FOR TERLIPRESSIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below